| Literature DB >> 9315593 |
F Leonardo1, G Fragasso, G M Rosano, P Pagnotta, S L Chierchia.
Abstract
Atenolol reduces QT dispersion and corrected QT interval in patients with syndrome X. This suggests that symptomatic improvement induced by atenolol in syndrome X patients may be partly related to reduction in abnormally augmented sympathetic tone.Entities:
Mesh:
Substances:
Year: 1997 PMID: 9315593 DOI: 10.1016/s0002-9149(97)00519-5
Source DB: PubMed Journal: Am J Cardiol ISSN: 0002-9149 Impact factor: 2.778